{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-022240","form_type":"8-K","ticker":"ZNTL","cik":"0001725160","company_name":"Zentalis Pharmaceuticals, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.251266+00:00","generated_at":"2026-06-14T00:23:06.477667+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Zentalis prices public offering of 11M shares at $22.66, raising ~$235.5M","bullets":["Sale of 11,032,656 common shares at $22.66 per share; net proceeds estimated at $235.5M.","Net proceeds to be used for ongoing and planned clinical trials and working capital.","Closing expected on June 20, 2023, subject to customary conditions.","Underwriters include Morgan Stanley, Jefferies, and SVB Securities.","Offering conducted under effective shelf registration statement on Form S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-022240","json":"https://secwatch.observer/filing/0001628280-23-022240.json","markdown":"https://secwatch.observer/filing/0001628280-23-022240.md","text":"https://secwatch.observer/filing/0001628280-23-022240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725160/000162828023022240/0001628280-23-022240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725160/000162828023022240/zntl-20230615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:23:06.477667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}